HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Madihally, S. V. Articles by Matthew, H. W.T. Search for Related Content PubMed PubMed Citation Articles by Madihally, S. V. Articles by Matthew, H. W.T.

Maintenance of CD34 Expression During Proliferation of CD34⁺ Cord Blood Cells on Glycosaminoglycan Surfaces

^a Department of Chemical Engineering and Materials Science, Wayne State University, Detroit, Michigan, USA;
^b Children's Hospital of Philadelphia, Abramson Pediatric Research Center, Philadelphia, Pennsylvania, USA

Key Words. Glycosaminoglycan • Heparin • Chondroitin sulfate • CD34⁺ cells • Chitosan • Proliferation

Dr. Howard Matthew, Wayne State University, Chemical Engineering & Materials Science Dept., 5050 Anthony Wayne Drive, Detroit, Michigan 48202, USA.

Recent studies have indicated that glycosaminoglycan (GAG) interactions with hematopoietic progenitors play a significant role in the regulation of hematopoiesis. However, the details of these interactions are not clear. In this study, we examined the role of soluble and immobilized GAGs in the proliferation of CD34⁺ cells. Chitosan, a cationic polysaccharide, was used to immobilize GAGs in ionic complex membranes. The GAGs studied were heparin, hyaluronate, and chondroitin sulfates A, B, and C. CD34-enriched umbilical cord blood cells were seeded onto tissue culture plates coated with the GAG-chitosan complex membranes. Cultures were maintained in medium supplemented with stem cell factor and interleukin 3 for up to six weeks, during which total and CD34⁺ cell numbers were determined by flow cytometry. Total cell number expansion ranged from 25-fold to 40-fold after six weeks. However, only heparin and chondroitin sulfate B (CSB) surfaces retained a significant CD34⁺ fraction. All other surfaces exhibited declines in CD34 expression, with negligible CD34⁺ percentages remaining after four weeks. In contrast, heparin and CSB surfaces exhibited CD34⁺ fractions as high as 90% after four weeks.

GAG desorption studies indicated that the observed effects were partly mediated by desorbed GAGs in a concentration dependent manner. Subsequent studies showed that sustained high (160 µg/ml) heparin levels had toxic effects, while the same concentration of CSB exhibited more rapid early proliferation of CD34⁺ cells. In conclusion, this culture system has demonstrated the ability to produce simultaneous proliferation and CD34⁺ cell enrichment of a partially purified cord blood population by controlling the nature and levels of GAG moieties to which the cells are exposed. The results indicate that specific GAGs can significantly influence the growth and differentiation characteristics of cultured CD34⁺ cells.